|
|
| | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid Basic information |
| Product Name: | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid | | Synonyms: | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid;Ganoderic acid S;Gaderic acid S;Lanosta-7,9(11),24-trien-26-oicacid, 3-oxo-, (24E)-;Ganoderic acid S1;(24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid | | CAS: | 104759-35-5 | | MF: | C30H44O3 | | MW: | 452.66856 | | EINECS: | | | Product Categories: | | | Mol File: | 104759-35-5.mol |  |
| | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid Chemical Properties |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder |
| | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid Usage And Synthesis |
| Description | A novel combination of triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS), the composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia. Ganoderic acid S and Mf induce mitochondria mediated apoptosis in human cervical carcinoma HeLa cells. | | Definition | ChEBI: Ganoderic acid S is a triterpenoid. |
| | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid Preparation Products And Raw materials |
|